ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003

Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds

September 26, 2003

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978

In Brief: ASCO Congratulates Klausner; UCLA Names Gasson Head Of Jonsson Center

August 4, 1995

Study Supports Immediate Breast Reconstruction

September 24, 2004